Bristol Myers SquibbSeattle, WA, United States
NA
(1545043) Lisocabtagene maraleucel (liso-cel) in R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): primary analysis of TRANSCEND CLL 004
Sunday, October 8, 20233:10 PM – 3:15 PM EDT